What is Noble Financial’s Forecast for GoHealth Q1 Earnings?

GoHealth, Inc. (NASDAQ:GOCOFree Report) – Equities research analysts at Noble Financial issued their Q1 2026 EPS estimates for GoHealth in a note issued to investors on Thursday, April 2nd. Noble Financial analyst M. Kupinski expects that the company will post earnings of ($2.49) per share for the quarter. Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Noble Financial also issued estimates for GoHealth’s Q2 2026 earnings at ($2.50) EPS, Q4 2026 earnings at ($1.58) EPS, FY2026 earnings at ($7.53) EPS and FY2027 earnings at ($4.12) EPS.

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of GoHealth in a research note on Monday, December 29th. One investment analyst has rated the stock with a Strong Buy rating, two have given a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat, GoHealth currently has a consensus rating of “Hold” and a consensus target price of $5.00.

Read Our Latest Stock Analysis on GOCO

GoHealth Price Performance

Shares of NASDAQ GOCO opened at $1.28 on Friday. GoHealth has a 52-week low of $1.26 and a 52-week high of $11.88. The firm has a fifty day moving average of $1.73 and a 200-day moving average of $2.78. The stock has a market capitalization of $36.61 million, a PE ratio of -0.07 and a beta of 1.61.

GoHealth (NASDAQ:GOCOGet Free Report) last posted its quarterly earnings results on Tuesday, March 31st. The company reported ($1.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($2.69) by $1.66. The company had revenue of $12.64 million for the quarter, compared to the consensus estimate of $88.62 million. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%.

Institutional Investors Weigh In On GoHealth

Several large investors have recently added to or reduced their stakes in the stock. Bank of America Corp DE lifted its stake in GoHealth by 22.8% in the fourth quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock valued at $105,000 after buying an additional 1,452 shares during the last quarter. Cubist Systematic Strategies LLC grew its position in shares of GoHealth by 297.3% during the first quarter. Cubist Systematic Strategies LLC now owns 10,915 shares of the company’s stock worth $134,000 after acquiring an additional 8,168 shares during the last quarter. Empowered Funds LLC increased its holdings in shares of GoHealth by 7.7% in the 1st quarter. Empowered Funds LLC now owns 25,008 shares of the company’s stock worth $307,000 after acquiring an additional 1,790 shares during the period. Jane Street Group LLC acquired a new stake in shares of GoHealth in the 1st quarter worth about $177,000. Finally, Geode Capital Management LLC lifted its position in GoHealth by 4.3% in the 2nd quarter. Geode Capital Management LLC now owns 118,961 shares of the company’s stock valued at $660,000 after purchasing an additional 4,955 shares during the last quarter. 24.21% of the stock is owned by institutional investors and hedge funds.

About GoHealth

(Get Free Report)

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.

Read More

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.